EHRA 2024: Late-Breaking Science Video Collection
Published: 22 April 2024
-
Views:
569
-
Likes:
7
-
Views:
569
-
Likes:
7
-
4m 54sPart 1 | Session 1 Venous Vascular Closure Vs Manual Compression: Style-AF Roland R Tilz
-
4m 3sPart 1 | Session 2 FIH Clinical Series of Conformable "Single Shot" PFA Catheter for PVI Vivek Reddy
-
8m 5sPart 1 | Session 3 Risk of Stroke or Embolism and AF: ARTESiA Substudy William McIntyre
-
2m 53sPart 1 | Session 4 Ablation Strategies for Repeat Procedures in Recurrent AF: ASTRO Boris Schmidt
-
5m 26sPart 1 | Session 5 Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH Julius Nikorowitsch
-
6m 51sPart 1 | Session 6 Personalised PVI: The QDOT-by-LAWT Trial Giulio Falasconi
-
7m 10sPart 1 | Session 7 AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease Laurent Fiorina
Overview
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Highlights
About the episode
EHRA 2024 — Dr Luigi Di Biase (Albert Einstein College of Medicine and Montefiore Medical Center, US) highlights 3 late-breaking trials from the 2024 EHRA scientific sessions. Discover the trials anticipated to reshape clinical practice as Dr Di Biase shares his insights.
Trials discussed in detail include:
00:36 - Novel Conformable "Single-Shot" PFA Catheter for Pulmonary Vein Isolation
01:08 - ASTRO - AF: Ablation STrategies for Repeat PrOcedures in Patients with Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation
01:57 - Style AF: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation
Recorded on-site at EHRA in Berlin, 2024.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editors: Jordan Rance, Mirjam Boros
Video Specialists: Oliver Miles, Dan Brent
Faculty Biographies
Luigi Di Biase
Section Head of Electrophysiology
Dr Luigi Di Biase is the Section Head of Electrophysiology at the Montefiore Medical Center in the Bronx, NY, US. He graduated summa cum laude from University of Bari's cardiology residency in 2000, and completed a master's degree of electrophysiology and cardiac pacing at the University of Insubria in Varese in 2006.
Dr Di Biase’s research focuses on cardiology and electrophysiology with specific emphasis on catheter ablation of atrial fibrillation and ventricular arrhythmias performed either manually or with robotic catheter navigation. Additionally, his research focuses on heart failure, particularly cases treated with cardiac resynchronization therapy devices.
Dr Di Biase has participated in over 450 published articles in indexed journals, and regularly presents data at international cardiology conferences.
Dr Di Biase is a member of the Arrhythmia & Electrophysiology Review editorial board.
Comments